13F
← All fund report cards

Moors & Cabot, Inc.

13F equity value
$2.3B
Positions
923
Top 10 concentration
25.0%
Quarters / total new picks
32 / 1,562
13F equity value over time
$0M$1B$2B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.1% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 56.2% of quarters (excess t = 1.36, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+2.2%
t-stat
1.36
Quarterly win rate
56%
Annualized excess
+1.5%
$1 → follow vs universe
$2.32 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.02820180630: follow 0.89820180930: follow 0.91720181231: follow 0.93720190331: follow 0.92420190630: follow 1.06920190930: follow 1.15220191231: follow 0.94620200331: follow 1.18120200630: follow 1.34820200930: follow 1.69120201231: follow 1.65220210331: follow 1.70220210630: follow 1.93020210930: follow 1.71720211231: follow 1.55820220331: follow 1.69020220630: follow 1.61120220930: follow 1.67620221231: follow 1.51320230331: follow 1.59920230630: follow 1.61320230930: follow 1.69220231231: follow 1.83420240331: follow 1.87220240630: follow 1.96520240930: follow 1.90920241231: follow 1.79420250331: follow 1.98320250630: follow 2.01420250930: follow 2.25520251231: follow 2.317 0.83 1.66 2.50 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 923 · 2026 Q1

Ticker Value Weight QoQ
AAPL $109M
4.7%
HOLD
NVDA $97M
4.1%
TRIM
TPL $81M
3.5%
HOLD
MSFT $75M
3.2%
HOLD
AMZN $48M
2.1%
HOLD
GOOGL $42M
1.8%
TRIM
JPM $37M
1.6%
TRIM
WMT $33M
1.4%
HOLD
XOM $32M
1.4%
TRIM
AVGO $30M
1.3%
TRIM
JNJ $29M
1.3%
HOLD
V $23M
1.0%
ADD
TJX $23M
1.0%
TRIM
META $22M
0.9%
HOLD
LLY $21M
0.9%
HOLD
RTX $21M
0.9%
TRIM
CVX $20M
0.9%
TRIM
IBM $19M
0.8%
TRIM
GOOG $18M
0.8%
HOLD
SPY $18M
0.8%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.